A group of scientists from the European Union dedicated to the investigation of the comorbidity of anxiety and depression with Parkinson’s disease are meeting between today and tomorrow in the city of Cuenca to advance in the study of the understanding of the neuronal alterations that occur in the brain during disease to aid in the prevention, diagnosis, and treatment of comorbidities.